BK vs CTKB · P/E 17, $94.14B cap vs rev $92.3M
The Bank of New York Mellon Corporation (BK) versus Cytek Biosciences Inc (CTKB) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. CTKB currently screens at market cap $421.8M.
Not investment advice. Open the BK and CTKB stock pages for the full models.
Not investment advice.